POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No44/2016
Date of issue:2016-05-11
Short name of the issuer
SOPHARMA AD
Subject
Notification
Official market - legal basis
Inne uregulowania
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that for April 2016 Sopharma AD realized a decrease of sales revenues of 19% compared to the same month of last year, including retention of the level of domestic sales and 29% decrease of export sales. For the first four months of 2016 sales revenues decreased by 4% compared to the same period of 2015, including a 6% increase of domestic sales and a 10% decrease of export sales. In the past two months there has been a sharp decline in the purchasing power of the population in Russia and conservative use of resources by households as the indexation of the prices has outpaced the indexation of wages. We expect that this trend will continue in the summer months, which are traditionally weak.
Annexes
FileDescription
inf_1 za kfn04 2016[1] ENG.docNotification
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2016-05-11Ognian DonevExecutive Director